Amyotrophic Lateral Sclerosis Clinical Trials in Boston, Massachusetts
13 recruitingBoston, Massachusetts
Showing 1–13 of 13 trials
Recruiting
Phase 2Phase 3
HEALEY ALS Platform Trial - Master Protocol
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD1,500 enrolled78 locationsNCT04297683
Recruiting
Phase 1Phase 2
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Amyotrophic Lateral Sclerosis
Vector Y Therapeutics12 enrolled11 locationsNCT07287397
Recruiting
Phase 3
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Amyotrophic Lateral Sclerosis
Prilenia500 enrolled5 locationsNCT07322003
Recruiting
EIM Via the Myolex mScan as an ALS Biomarker
Amyotrophic Lateral Sclerosis
Beth Israel Deaconess Medical Center80 enrolled6 locationsNCT06491732
Recruiting
Not Applicable
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Amyotrophic Lateral Sclerosis
Paradromics2 enrolled3 locationsNCT07357428
Recruiting
A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis
Biogen125 enrolled1 locationNCT07259980
Recruiting
Intermuscular Coherence as a Biomarker for ALS
Amyotrophic Lateral Sclerosis
University of Chicago650 enrolled4 locationsNCT05104710
Recruiting
PREVENT ALL ALS Study
Amyotrophic Lateral Sclerosis
St. Joseph's Hospital and Medical Center, Phoenix600 enrolled32 locationsNCT06581861
Recruiting
ASSESS ALL ALS Study
Amyotrophic Lateral Sclerosis
St. Joseph's Hospital and Medical Center, Phoenix2,000 enrolled32 locationsNCT06578195
Recruiting
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
Movement DisordersAmyotrophic Lateral SclerosisDegenerative Disorder+1 more
Target ALS Foundation, Inc.1,000 enrolled12 locationsNCT05137665
Recruiting
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Amyotrophic Lateral SclerosisCorticobasal Degeneration (CBD)Progressive Supranuclear Palsy (PSP)+11 more
Mayo Clinic2,100 enrolled27 locationsNCT04363684
Recruiting
Phase 2Phase 3
RAPA-501 Therapy for ALS
Amyotrophic Lateral Sclerosis
Rapa Therapeutics LLC41 enrolled1 locationNCT04220190
Recruiting
Phase 1
A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS
Amyotrophic Lateral Sclerosis
ProJenX72 enrolled4 locationsNCT05279755